Press & news - FluoGuide A/S

5 November, 2025 FluoGuide strengthens leadership to advance clinical program and regulatory approval strategy News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR

Copenhagen, Denmark 4 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...

5 November, 2025 FluoGuide convenes an extraordinary general meeting News Corporate Information General meeting Notice English Regulatory Listing Regulation IR

Copenhagen, Denmark 4 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby invites shareholders...

3 November, 2025 FluoGuide A/S issue warrants to board members, executive management and employees News Corporate Action Other mfn-ext-nq mfn-ext-nq-corporate-action English Regulatory Listing Regulation IR

Copenhagen, Denmark, 3 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) announces that it...

3 November, 2025 Share transfer and ownership restructuring – related party transaction News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English Regulatory MAR IR

FluoGuide A/S announces that two of its shareholders, both of whom hold management and/or board positions in the Company, have entered...

3 November, 2025 FluoGuide A/S completes directed share issue of SEK 104 million News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-inside-information English Regulatory MAR IR

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA...

3 November, 2025 FluoGuide A/S intends to carry out a directed share issue of approximately SEK 100 million News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-inside-information English Regulatory MAR IR

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA...

28 October, 2025 FluoGuide in advanced negotiations on collaboration agreement with a world leading medical technology company News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-inside-information English Regulatory MAR IR

Copenhagen, Denmark, 28 October 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...

6 October, 2025 Positive interim results from an investigator-initiated study of FG001 in meningioma and low-grade glioma surgery, presented at EANS News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR

Copenhagen, Denmark, 6 October 2025 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech...

16 September, 2025 FluoGuide receives positive FDA feedback on FG001 in high-grade glioma News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-listing English Regulatory Listing Regulation IR

Copenhagen, Denmark, 16 September 2025 – FluoGuide A/S ("FluoGuide" or the "Company") received positive feedback...

2025

FluoGuideCalendar & events